These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 37395022)
1. Expression Pattern and Prognostic Analysis of Branched-Chain Amino Acid Catabolism-Related Genes in Non-Small Cell Lung Cancer. Yao X; Deng Y; Zhou J; Jiang L; Song Y Front Biosci (Landmark Ed); 2023 Jun; 28(6):107. PubMed ID: 37395022 [TBL] [Abstract][Full Text] [Related]
2. System analysis of Situ Y; Gao R; Lei L; Deng L; Xu Q; Shao Z Int J Biol Markers; 2022 Jun; 37(2):158-169. PubMed ID: 35254116 [TBL] [Abstract][Full Text] [Related]
3. Downregulation of HOXA3 in lung adenocarcinoma and its relevant molecular mechanism analysed by RT-qPCR, TCGA and in silico analysis. Gan BL; He RQ; Zhang Y; Wei DM; Hu XH; Chen G Int J Oncol; 2018 Oct; 53(4):1557-1579. PubMed ID: 30066858 [TBL] [Abstract][Full Text] [Related]
4. A prognosis-related molecular subtype for early-stage non-small lung cell carcinoma by multi-omics integration analysis. Yang K; Wu Y BMC Cancer; 2021 Feb; 21(1):128. PubMed ID: 33549049 [TBL] [Abstract][Full Text] [Related]
5. ERCC6L is a biomarker and therapeutic target for non-small cell lung adenocarcinoma. Hou G; Lu Z; Bi Y; Deng J; Yang X Med Oncol; 2022 Feb; 39(5):51. PubMed ID: 35150321 [TBL] [Abstract][Full Text] [Related]
6. Exploring and comparing of the gene expression and methylation differences between lung adenocarcinoma and squamous cell carcinoma. Yang Y; Wang M; Liu B J Cell Physiol; 2019 Apr; 234(4):4454-4459. PubMed ID: 30317601 [TBL] [Abstract][Full Text] [Related]
7. Comparative study on the mutational profile of adenocarcinoma and squamous cell carcinoma predominant histologic subtypes in Chinese non-small cell lung cancer patients. Ding Y; Zhang L; Guo L; Wu C; Zhou J; Zhou Y; Ma J; Li X; Ji P; Wang M; Zhu W; Shi C; Li S; Wu W; Zhu W; Xiao D; Fu C; He Q; Sun R; Mao X; Lizaso A; Li B; Han-Zhang H; Zhang Z Thorac Cancer; 2020 Jan; 11(1):103-112. PubMed ID: 31692283 [TBL] [Abstract][Full Text] [Related]
8. Bioinformatics analysis of differentially expressed miRNAs in non-small cell lung cancer. Yu H; Pang Z; Li G; Gu T J Clin Lab Anal; 2021 Feb; 35(2):e23588. PubMed ID: 32965722 [TBL] [Abstract][Full Text] [Related]
9. Differential prognostic impact and potential molecular mechanisms of PCDHGA12 expression in lung adenocarcinoma and squamous cell carcinoma. Xu X; Zhang J; Yao T; Zhao X; Wu Q; Lu C; Guo X; Xie S; Qiu L; Bi R; Xue H Int Immunopharmacol; 2024 Sep; 139():112727. PubMed ID: 39067405 [TBL] [Abstract][Full Text] [Related]
10. Association of TOP2A and ADH1B with lipid levels and prognosis in patients with lung adenocarcinoma and squamous cell carcinoma. Yin D; Zhang Y; Li H; Cheng L Clin Respir J; 2023 Dec; 17(12):1301-1315. PubMed ID: 37985446 [TBL] [Abstract][Full Text] [Related]
11. Zhang W; Li T; Hu B; Li H Technol Cancer Res Treat; 2020; 19():1533033820957030. PubMed ID: 33084541 [TBL] [Abstract][Full Text] [Related]
12. Bioinformatic analysis revealing mitotic spindle assembly regulated NDC80 and MAD2L1 as prognostic biomarkers in non-small cell lung cancer development. Wei R; Wang Z; Zhang Y; Wang B; Shen N; E L; Li X; Shang L; Shang Y; Yan W; Zhang X; Ma W; Wang C BMC Med Genomics; 2020 Aug; 13(1):112. PubMed ID: 32795325 [TBL] [Abstract][Full Text] [Related]
13. Ferroptosis-Related Genes Are Potential Therapeutic Targets and the Model of These Genes Influences Overall Survival of NSCLC Patients. Zhang N; Wu Y; Wu Y; Wang L; Chen J; Wang X; Chard Dunmall LS; Cheng Z; Wang Y Cells; 2022 Jul; 11(14):. PubMed ID: 35883650 [TBL] [Abstract][Full Text] [Related]
14. Elevated PHD2 expression might serve as a valuable biomarker of poor prognosis in lung adenocarcinoma, but no lung squamous cell carcinoma. Xu XL; Gong Y; Zhao DP Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8731-8739. PubMed ID: 30575913 [TBL] [Abstract][Full Text] [Related]
15. High ECT2 expression is an independent prognostic factor for poor overall survival and recurrence-free survival in non-small cell lung adenocarcinoma. Zhou S; Wang P; Su X; Chen J; Chen H; Yang H; Fang A; Xie L; Yao Y; Yang J PLoS One; 2017; 12(10):e0187356. PubMed ID: 29088286 [TBL] [Abstract][Full Text] [Related]
16. GPC3 affects the prognosis of lung adenocarcinoma and lung squamous cell carcinoma. Ning J; Jiang S; Li X; Wang Y; Deng X; Zhang Z; He L; Wang D; Jiang Y BMC Pulm Med; 2021 Jun; 21(1):199. PubMed ID: 34112123 [TBL] [Abstract][Full Text] [Related]
17. Molecular subtypes based on DNA methylation predict prognosis in lung squamous cell carcinoma. Li XS; Nie KC; Zheng ZH; Zhou RS; Huang YS; Ye ZJ; He F; Tang Y BMC Cancer; 2021 Jan; 21(1):96. PubMed ID: 33485313 [TBL] [Abstract][Full Text] [Related]
18. Epigenetic loss of putative tumor suppressor SFRP3 correlates with poor prognosis of lung adenocarcinoma patients. Schlensog M; Magnus L; Heide T; Eschenbruch J; Steib F; Tator M; Kloten V; Rose M; Noetzel E; Gaisa NT; Knüchel R; Dahl E Epigenetics; 2018; 13(3):214-227. PubMed ID: 27623992 [TBL] [Abstract][Full Text] [Related]
19. [Identification of differentially expressed genes between lung adenocarcinoma and squamous cell carcinoma using transcriber signature analysis]. Peng S; Li X; Liu Q; Zhang Y; Zou L; Gong X; Wang M; Ma X Nan Fang Yi Ke Da Xue Xue Bao; 2019 Jun; 39(6):641-649. PubMed ID: 31270041 [TBL] [Abstract][Full Text] [Related]
20. Blood FOLR3 methylation dysregulations and heterogeneity in non-small lung cancer highlight its strong associations with lung squamous carcinoma. Qu Y; Zhang X; Qiao R; Di F; Song Y; Wang J; Ji L; Zhang J; Gu W; Fang Y; Han B; Yang R; Dai L; Ouyang S Respir Res; 2024 Jan; 25(1):59. PubMed ID: 38273401 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]